Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,898 results that match your search.21,898 results
  • At a time when more companies and individuals around the world are discovering the value of IP, it seems that for IP owners the search for the best protection systems and infringement defence mechanisms has never been so crucial. The choice is wide. Companies can mediate, arbitrate or go to the courts, though the question of where to litigate has never been more confusing.
  • Regina Neuefeind and Martin Huenges of Maiwald Patentanwalts GmbH in Munich examine the lessons of some recent biotech decisions from the European Patent Office
  • Axel von Hellfeld of Wuesthoff & Wuesthoff in Munich examines how the US and German courts treat questions of equivalence, and highlights a key difference between the two systems
  • Reinhardt Schuster, of Bardehle Pagenberg Dost Altenburg Geissler in Munich and Düsseldorf, looks at the advantages of patent infringement litigation in Germany
  • The reputation of Munich's Max Planck Institute demonstrates why IP is serious business in Germany - but the challenge now is to spread the message beyond the legal and business cognoscenti. James Nurton reports
  • Joyce A Tan & Partners in Singapore look at the proposed changes to Singapore's competition regime, and the effect they will have on IP licensing agreements
  • Keith Callinan of Alban Tay Mahtani & De Silva reviews the changes recently made to Singapore's Patents Act, and explains how they will affect applicants
  • Morris John, Penny Leng and Gerald Koh of Drew & Napier in Singapore review some important patent and trade mark decisions which demonstrate the courts' increasingly stringent stance on IP infringement
  • Singapore has gone all out to position itself as an international biotech and pharmaceutical R&D centre. As more and more companies pour money into the island state, Emma Barraclough looks at how Singapore became the darling of the biomedical multinationals
  • July 1 saw the introduction of a new intellectual property regime in Singapore after the country overhauled its rules on patents, trade marks, copyright and protection for plant varieties. Emma Barraclough spoke to Lee Li Choon, director of trade marks at the Intellectual Property Office of Singapore (IPOS) and Chiam Lu Lin, IPOS’s assistant director-general of registries, about what the changes to the law mean for IP owners